Mark A Moyad Mark C Scholz
10.2147/RRU.S63136
Res Rep Urol
2014 Jul 16;6:71-7.
5α-reductase inhibitors active surveillance dietary supplements enzalutamide prostate cancer
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/25157338/
Review
PMC4106964
25157338
Short-term enzalutamide treatment for the potential remission of active surveillance or intermediate-risk prostate cancer: a case study, review, and the need for a clinical trial
2014